Trial intelligence / Profile preview

Long-term Persistence of Twinrix in Adolescents (Years 11-15)

NCT00875485Phase 4Completed

Sponsor
GSK
Start
May 2009
Primary completion
Jul 2014
Modality
Vaccines & Immunotherapeutics
Countries
2
01

Overview

A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis A (HAV), hepatitis B (HBV), sponsored by GSK. Started May 2009; status: completed.

02

Drugs

hepatitis b vaccine recombinant
03

Conditions

hepatitis A (HAV)hepatitis B (HBV)

Beyond the preview

Go deeper on NCT00875485.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00875485.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call